Prepared by Dr. Marcus Thorne, FRM, Head of Quantitative Research | Reviewed by Yuki Tanaka, Lead Editor | Report ID: IGEMINI-2B8AD9A1-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns neurolink stock a Cautiously Constructive outlook for the next quarter. Key drivers include a P/E of 76.44x, 44.4% revenue expansion, and an RSI of 55 suggesting a neutral-bullish phase. We define critical support at $791.1 and resistance at $966.9.
Rating: Buy | Target Price: $1204.23 | Next Earnings: Jun 28
Download Full PDF Report
Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.
On-chain money flow shows 27%% increase in smart money index, reinforcing the technical setup.
MACD printed a Neutral as the 50-day SMA turned positive 23 days ago.
Relative to Energy peers, neurolink stock sits at the 66th percentile in valuation, offering a potential value opportunity.
Free cash flow conversion remains robust at 70%, supporting the 3.61% dividend and buybacks.
EPS of $11.5 reveals resilient earnings quality. DuPont analysis highlights margin expansion as the key ROE driver.
Beta of 1.72 suggests neurolink stock is {beta_desc} volatile than the market, influencing hedging strategies.
Dark pool prints show a 14%% surge in block trades, indicating institutional accumulation before Jun 28 earnings.
Short float at 8.8% is below the sector average, reducing squeeze risk. Institutional ownership is 62%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $879 | $835.05 |
| Market Cap | $21.59B | $17.27B |
| P/E Ratio | 76.44x | 65x |
| EPS (TTM) | $11.5 | $10.35 |
| Dividend Yield | 3.61% | 2.5% |
| Revenue Growth | 44.4% | 26.6% |
| Target Price | $1204.23 | - |
| Beta | 1.72 | 1.00 |